Medical News |
- Impulsiveness linked to bipolar disorder severity
- Interhemispheric coordination reduced in schizophrenia
- HPV genotype may alter chemoradiotherapy outcome
- Talk smoothes the way to better understanding sick babies
- Working out during pregnancy wards off muscle pain
- Calls for more widespread safety information on PGD
- HPV genotype may alter chemoradiotherapy outcome
- Enzalutamide extends castration-resistant prostate cancer survival
| Impulsiveness linked to bipolar disorder severity Posted: 20 Aug 2012 05:00 PM PDT Trait impulsiveness is associated with a severe course of bipolar disorder, researchers report. |
| Interhemispheric coordination reduced in schizophrenia Posted: 20 Aug 2012 05:00 PM PDT Results from a US study show that patients with schizophrenia have significantly decreased interhemispheric coordination compared with mentally healthy individuals. |
| HPV genotype may alter chemoradiotherapy outcome Posted: 19 Aug 2012 05:00 PM PDT Human papillomavirus genotype predicts whether patients with cervical cancer will benefit from concurrent chemoradiation therapy, study findings suggest. |
| Talk smoothes the way to better understanding sick babies Posted: 19 Aug 2012 05:00 PM PDT Clinicians must foster improved communication with the mothers of critically ill newborns to improve understanding of their child's condition, research suggests. |
| Working out during pregnancy wards off muscle pain Posted: 19 Aug 2012 05:00 PM PDT Not enough healthy pregnant women are doing the recommended amount of physical exercise, suggest study findings. |
| Calls for more widespread safety information on PGD Posted: 19 Aug 2012 05:00 PM PDT The informed consent process for prospective parents considering prenatal genetic diagnosis may be inadequate due to a lack of disclosure by fertility clinics about the risks involved in the procedure, says a US researcher. |
| HPV genotype may alter chemoradiotherapy outcome Posted: 19 Aug 2012 05:00 PM PDT Human papillomavirus genotype predicts whether patients with cervical cancer will benefit from concurrent chemoradiation therapy, study findings suggest. |
| Enzalutamide extends castration-resistant prostate cancer survival Posted: 19 Aug 2012 05:00 PM PDT Enzalutamide treatment significantly improves survival in men with castration-resistant prostate cancer, demonstrate phase III trial results published in TheNew England Journal of Medicine. |
| You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google Inc., 20 West Kinzie, Chicago IL USA 60610 | |
No comments:
Post a Comment